Biologics for the 21st century.
About IDT Biologika

Biotechnology for people and animals — carrying a strong tradition into the future

At IDT Biologika, we are an international leader in the field of biotechnology, a key global technology for the 21st century. Our 95-year tradition of manufacturing vaccines and pharmaceuticals motivates and obligates us to continue our work in improving the health of humans and animals, now and going forward. Today, our company ranks among the top echelon of innovative high-tech life science companies, delivering a consistent level of quality in the standardized production of biopharmaceuticals. We have achieved this position through our commitment to employing highly qualified staff, using state-of-the-art production technologies, and strongly investing in research and development.

Award-winning innovation and quality — IDT focuses on contract manufacturing and animal health. IDT Biologika has received international accolades for the development and manufacturing of new vaccines, as well as its own trail-blazing products in animal health.

IDT Biologika acquires Dr. Felgenträger, located in the BioPharmaPark Dessau

Tuesday, 24. April 2018

The pharmaceuticals company intends to use this takeover to continue expanding its herd-specific vaccine business more info

CMO Leadership Award 2018

Monday, 26. March 2018

IDT Biologika receives three Life Science Leader’s more info

A second managing director for IDT Biologika

Monday, 19. February 2018

Our new senior management team is now complete more info

Official transfer of ownership

Tuesday, 21. November 2017

Former Schade brewery grounds handed off to IDT Biologika more info

Plans to Build Out New, State-of-the-Art Vaccine Manufacturing Hub in Ontario

Monday, 21. August 2017

Plans to Build Out New, State-of-the-Art Vaccine Manufacturing Hub in Ontario more info

Twitter
@IDT Biologika

Monday, 26. March 2018

RT @BIODeutschland: Treffen Sie @idtbiologika auf den #DBT2018 in #Berlin https://t.co/T7qovQmuTj more info

Tuesday, 13. March 2018

RT @reinerhaseloff: IDT Biologika Dessau-Roßlau feiert 25 Jahre erfolgreiche Privatisierung! 400 Mio € Investitionen, 2018 weitere 60 Mio €… more info

Saturday, 10. March 2018

RT @RfwrightLSL: Congratulations #CMOAwards18 winners! @cambrex @CatalentPharma Bloomington & San Diego @ChemConGmbH @CobraBiologics @corde… more info

IDT Biologika inaugurates its new research and development building in Riems more info

Dessauer high school students support planting initiative more info

Official transfer of ownership more info

Contact & Address

IDT as employer — Jobs for the future more info